Endocrinology & metabolism
Hormones & metabolism clinical trials
Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We’re tracking 7,607 recruiting studies in this area right now.
By phase
- Not applicable5,335
- Phase 2607
- Phase 1557
- Phase 3417
- Phase 4318
- Phase 1/Phase 2288
- Phase 2/Phase 385
Top conditions
- Obesity619
- Ovarian Cancer336
- Pancreatic Cancer289
- Type 2 Diabetes276
- Diabetes192
- Diabetes Mellitus183
- Diabetes Mellitus, Type 2170
- Hypertension138
- Type 1 Diabetes130
- Metabolic Syndrome126
- Obesity & Overweight123
- Breast Cancer111
- Overweight106
- Cardiovascular Diseases105
- Amyotrophic Lateral Sclerosis102
- Colorectal Cancer92
- Pancreas Cancer90
- Endometrial Cancer87
Leading sponsors
- Mayo Clinic87
- Novo Nordisk A/S64
- University of Colorado, Denver53
- Assistance Publique - Hôpitaux de Paris52
- M.D. Anderson Cancer Center41
- Massachusetts General Hospital41
- Eli Lilly and Company40
- IRCCS Azienda Ospedaliero-Universitaria di Bologna40
- National Taiwan University Hospital40
- Cairo University38
Where studies are running
- California521
- Maryland180
- Alabama176
- Arizona170
- Florida166
- Texas158
- Massachusetts151
- New York142
- Colorado115
- Pennsylvania113
Recruiting studies7,607 total
- NCT07801001Enrolling by invitation
Zinc supplements for women with polycystic ovary syndrome
This study tests whether taking zinc supplements can improve insulin resistance and reduce symptoms in women with polycystic ovary syndrome (PCOS). If you have PCOS and are not pregnant, you may be able to join.
DhakaAges 18–45 - NCT07807280Recruiting
Learning carb counting with a continuous glucose monitor
This study tests a new way to learn carb counting using a continuous glucose monitor (CGM). It may help you improve your blood sugar control without needing more injections.
Los Angeles, CaliforniaAges 18 years+ - NCT07803185Recruiting
Emotional eating and anhedonia with weight loss medications
This study looks at how GLP-1 weight loss medications affect emotional eating (eating in response to feelings) and anhedonia (loss of interest or pleasure). If you're starting one of these drugs for weight loss, your participation may help understand these side effects.
Kayseri, MelikgaziAges 18 years+ - NCT07806383Enrolling by invitation
Effects of a sugar-based supplement on heart and gut health in overweight adults
This study tests a sugar-based supplement (a synbiotic) to see if it improves heart and metabolic health markers as well as gut health in people who are overweight but otherwise healthy. You will take the supplement for a period of time, and your health will be monitored.
NaplesAges 20–70 - NCT06500754Recruiting
Persistent intestinal damage in celiac disease on strict diet
This study looks at why some adults with celiac disease still have damage to their small intestine even after strictly avoiding gluten. It aims to understand persistent villous atrophy and could help improve long-term care for people like you.
Terrassa, BarcelonaAges 20–80 - NCT06510543Recruiting
Nutrition drink before and after esophageal cancer surgery
This study tests a special nutrition drink (ORAL IMPACT®) before and after esophageal cancer surgery. It aims to help patients who are malnourished get stronger and recover better.
Beijing, Beijing MunicipalityAges 18–80 - NCT06513247Recruiting
Screening for type 1 diabetes in high-risk relatives
This study screens high-risk children for early signs of type 1 diabetes by testing relatives who already have the condition. It aims to catch diabetes early so treatment can start sooner.
RiyadhAges 2–18 - NCT06513676Recruiting
Adrenal artery treatment for aldosteronism study
This study tests a procedure that blocks tiny arteries in the adrenal gland to treat high blood pressure and low potassium caused by aldosteronism. It may be an option if you cannot take medications or cannot have surgery.
Ürümqi, XinjiangAges 18–60 - NCT03966612Recruiting
Monitoring people with MEN1 and related hormone gland tumors
This study follows people who have Multiple Endocrine Neoplasia type 1 (MEN1), a genetic condition that can cause tumors in hormone glands. It aims to monitor symptoms and lesions over time to better understand how the condition progresses and how to manage it.
DijonAges Any age - NCT07796503Recruiting
Comparing two ways to measure the bypass in weight-loss surgery
This study compares two methods for choosing the length of the intestinal bypass in a weight-loss surgery called one-anastomosis gastric bypass. It may help improve weight loss and reduce complications.
AlmatyAges 18–65 - NCT07795164RecruitingPhase 3
Study of pemvidutide for liver scarring from MASH
This study tests an investigational medicine called pemvidutide to see if it can reduce liver scarring in people with MASH (a liver condition linked to excess weight and metabolic issues). It may help improve liver health and potentially slow or reverse the condition.
North Little Rock, ArkansasAges 18–75 - NCT07797855RecruitingPhase 1
Testing a new medicine's safety in healthy people
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
GroningenAges 18–55 - NCT07793929RecruitingPhase 1
Kidney function and study drug levels
This study checks how different levels of kidney function affect the levels of a new investigational drug called Ribupatide in the blood. It helps doctors understand how the drug works in people with various kidney conditions.
Orlando, FloridaAges 18–85 - NCT07793019RecruitingPhase 1
Weight loss and safety study in overweight adults
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
Beijing, Beijing MunicipalityAges 18–55 - NCT07799688RecruitingPhase 2
Study of a new drug for high triglycerides
This study tests a new drug, HRS-7249, to see if it safely lowers high triglyceride levels (a type of fat in the blood) that can increase the risk of heart problems. It is for people who either were in the earlier study of this drug or are new participants with high triglycerides.
Jinan, ShandongAges 18–79 - NCT07794579RecruitingPhase 3
Study of orforglipron for people with overweight at risk of health problems
This trial tests a new medicine, orforglipron, to help people with overweight who are at risk of developing weight-related health issues. It aims to see if the medicine can help with weight management and reduce risks before more serious conditions develop.
Anniston, AlabamaAges 18 years+ - NCT07797335RecruitingPhase 3
Zenagamtide for diabetes and weight loss
This study compares a new once-weekly injection to lower blood sugar levels against a standard daily injection in people with type 2 diabetes who are at high risk for heart problems. It aims to find out if the new medicine is more effective in managing blood sugar and body weight.
Birmingham, AlabamaAges 45 years+ - NCT06519552RecruitingPhase 1
Gene therapy study for adults with MPS type I
This study tests a new gene therapy called JWK008 for adults with MPS type I. The goal is to see if it is safe and can help improve symptoms. You may be able to join if you are 18 or older and have not had serious side effects from enzyme replacement therapy.
Chengdu, SichuanAges 18 years+ - NCT05593679Recruiting
Registry study for heart PYP scans in possible ATTR amyloidosis
This study collects information from adults who have been diagnosed with, or are being checked for, ATTR amyloidosis (a condition where abnormal protein builds up in the body) using a heart PYP scan. Your participation may help doctors better understand how these scans relate to diagnosis and follow-up over time.
New Taipei CityAges 20 years+ - NCT06523582Recruiting
Genetic study of neuroendocrine tumors in Mexican patients
This study aims to find genetic causes of neuroendocrine tumors in Mexican patients. By understanding your DNA, researchers hope to improve diagnosis and treatment for people with these rare conditions.
Mexico City, Mexico CityAges 18 years+ - NCT07793487Enrolling by invitation
Testing a special dairy drink for gut and metabolic health
This study tests whether a special dairy product can help improve symptoms in people with irritable bowel syndrome or early signs of metabolic syndrome. Participants must be at a healthy weight and not have other major health conditions or be on certain diets.
WarsawAges 18 years+ - NCT07797374Recruiting
Nausea, vomiting, and pain after weight-loss surgery
This study looks at how patients feel after weight-loss surgery, specifically nausea, vomiting, and pain. It uses national registry data to understand these symptoms better, which may help improve care for future patients.
SundsvallAges 18 years+ - NCT07798960RecruitingPhase 2
Light therapy for diabetic foot ulcers
This study tests whether shining a special light on diabetic foot ulcers can help them heal faster. It aims to find out if the treatment is safe and effective.
Teresina, PiauíAges 18 years+ - NCT07799948Recruiting
Stent adjustment for repeated confusion after liver shunt
This study tests a procedure to narrow a stent in the liver to reduce episodes of confusion caused by toxins reaching the brain. It may help people who still have frequent confusion despite standard treatments.
Xi'an, ShaanxiAges 18 years+
Common questions
- How many hormones & metabolism clinical trials are recruiting?
- Clin2 is tracking 7,607 recruiting endocrinology & metabolism studies from the U.S. registry right now, out of 11,814 we cover in this area in total.
- What does “Hormones & metabolism” cover here?
- Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We group each study into hormones & metabolism based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a hormones & metabolism trial near me?
- Use the search to filter hormones & metabolism studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.